169 Virgin Olive Oil Benefits Figure 14.1. Cancer worldwide and in Spain (2020). a) Age-standardized incidence and mortality rates (worldwide) for the 10 main cancers. Source: “Global Cancer Observatory” (GLOBOCAN). “International Agency for Research on Cancer”. “World Health Organization”. 2020. Available at: https://gco.iarc.fr/today/home (last accessed September 2025). b) Estimated cancer incidence (number of new cases) in Spain by gender and type of cancer. “Spanish network for cancer registries” (REDECAN). 2020. Available at: https://www.google.es/ url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjK5Pm7_8z2AhWjy4UKHYnsAxQQ FnoECAcQAQ&url=https%3A%2F%2Fwww.caib.es%2Fsites%2Festrategiacancer%2Fca%2Fregistre_ de_cancer_de_mallorca%2Farchivopub.do%3Fctrl%3DMCRST8485ZI308370%26id%3D308370&usg =AOvVaw0K_ cLKBos6tdVe-3xmK32P (last accessed September 2025). nosed with cancer, and more than ten million die from this disease. Cancer is the second leading cause of death after cardiovascular diseases, yet it ranks first when considering premature deaths, using potential years of life lost as the indicator. Figure 14.1 shows the situation of cancer in 2020 worldwide and in Spain. 10 20 30 40 50 60 0 10 20 30 40 50 60 47.8 30.7 22.4 19.5 13.3 11.1 9.5 8.7 6.6 6.6 13.6 7.7 18.0 9.0 7.3 7.7 8.7 1.8 4.2 0.43 Age-standardized rate-ASR(worldwide) per 100,000 Incidence Mortality a) 0 30.000 40.000 10.000 20.000 Prostate Lung Urinary bladder Colon Other Rectum Oropharynx Kidney (excluding renal pelvis) (excluding renal pelvis) Liver Lymphoma (Non-Hodgkin) Stomach Pancreas Leukemias Larynx Skin melanoma Encephalon and NS Esophagus Myeloma Gallbladder Testicular Thyroid Hodgkin lymphoma b) 0 10.000 20.000 30.000 40.000 Breast Colon Lung Other Corpus uteri Rectum Urinary bladder Lymphoma (Non-Hodgkin) Thyroid Pancreas Skin melanoma Ovarium Stomach Leukemias Oropharynx Kidney (excluding renal pelvis) Encephalon and NS Uterine cervix Liver Gallbladder Myeloma Hodgkin lymphoma Esophagus Larynx Incidence (number of cases) Incidence (number of cases) WOMEN MEN 10 20 30 40 50 60 0 10 20 30 40 50 60 47.8 30.7 22.4 19.5 13.3 11.1 9.5 8.7 6.6 6.6 13.6 7.7 18.0 9.0 7.3 7.7 8.7 1.8 4.2 0.43 Age-standardized rate-ASR (worldwide) per 100,000 Incidence Mortality a) 0 30.000 40.000 10.000 20.000 Prostate Lung Urinary bladder Colon Other Rectum Oropharynx Kidney (excluding renal pelvis) (excluding renal pelvis) Liver Lymphoma (Non-Hodgkin) Stomach Pancreas Leukemias Larynx Skin melanoma Encephalon and NS Esophagus Myeloma Gallbladder Testicular Thyroid Hodgkin lymphoma b) 0 10.000 20.000 30.000 40.000 Breast Colon Lung Other Corpus uteri Rectum Urinary bladder Lymphoma (Non-Hodgkin) Thyroid Pancreas Skin melanoma Ovarium Stomach Leukemias Oropharynx Kidney (excluding renal pelvis) Encephalon and NS Uterine cervix Liver Gallbladder Myeloma Hodgkin lymphoma Esophagus Larynx Incidence (number of cases) Incidence (number of cases) WOMEN MEN Breast Prostate Lung Colon and rectum Uterine cervix Stomach Liver Corpus uteri Ovary Thyroid - (i\ GLOBA(LAN(ER lntemationAalgencfyorResearcohnCancer \el OBSERVATORY f.,\W011d_He,1th ~Orgamzation
RkJQdWJsaXNoZXIy Njg1MjYx